Nyrada
Menu
NYR:
Market Cap*:
Price Delay ~20min
Home
About Us
Company Overview
Board of Directors
Management
Scientific Advisory Board
Corporate Governance
Our Science
Lead Drug Development
Brain Injury Program
Cholesterol Lowering Program
Technical Glossary
Drug Development Pathway
Investors
Investor Welcome
ASX Announcements
Brain Injury Program
Cholesterol-Lowering Program
Financial Reports
Corporate Announcements
Investor Presentations
Share Price Information
Key Dates
Investors Glossary
Annual Reports
Analyst Reports
Annual General Meeting
Past Shareholder Meetings
News & Insights
Presentations & Interviews
Media
Newsletters
Publications
Contact Us
Contact Us
Working at Nyrada
Email Alerts
Investors
Home
>
Investors
>
ASX Announcements
Investor Welcome
ASX Announcements
Brain Injury Program
Cholesterol-Lowering Program
Financial Reports
Corporate Announcements
Investor Presentations
Share Price Information
Key Dates
Investors Glossary
Annual Reports
Analyst Reports
Annual General Meeting
Past Shareholder Meetings
ASX Announcements
Filter by Year:
2023
2022
2021
2020
20-Nov-2023
Nyrada Annual General Meeting Results
20-Nov-2023
Nyrada AGM 2023 CEO Presentation
20-Nov-2023
Nyrada AGM 2023 Chair Address
1-Nov-2023
2023 AGM Chair Letter to Shareholders
17-Oct-2023
2023 AGM Notice of Meeting and Proxy
17-Oct-2023
2023 AGM Letter to Shareholders and Proxy
13-Oct-2023
Quarterly Activities Report and Appendix 4C
28-Aug-2023
Nyrada Full Year Results FY2023
28-Aug-2023
Annual Report for year ended 30 June 2023
28-Aug-2023
Preliminary Final Report
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
Next
